| abstract |
The present invention offers an anti-hyperlipemia composition, containing Acipimox and Rosuvastatin, or their salts, esters and solvates. The proportion by weight is (15-100):1, preferably (40-100):1, more preferably 60:1. Acipimox can be used in combination with Rosuvastatin in synergistic action, the effect of anti-hyperlipemia is better than the combination of Acipimox and Lovastatin. |